Law firm Faruqi & Faruqi calls for lead plaintiffs in Capricor Therapeutics securities class action ahead of September 28 deadline
Executive summary: The law firm Faruqi & Faruqi is urging investors who suffered financial losses in Capricor Therapeutics to seek counsel before the September 28, 2026, deadline to lead a securities class action lawsuit. The appointment of a lead plaintiff is a decisive step in securities litigation that determines who will direct the settlement negotiations or trial proceedings, impacting how much recovery shareholders might receive.
Who is involved: Capricor Therapeutics, Inc. (NASDAQ: CAPR), Faruqi & Faruqi, LLP, and affected shareholders.
Likely next: The submission of lead plaintiff motions by interested investors before the September 28 deadline.
Faruqi & Faruqi, LLP has issued a formal solicitation for investors of Capricor Therapeutics (NASDAQ: CAPR) to organize a lead plaintiff group for a securities class action. This move follows reports of substantial investor losses and aims to establish a representative for the litigation. The deadline of September 28, 2026, serves as a critical procedural milestone for the potential lawsuit.
What's next — scenarios
Base Case: Lead plaintiff appointed (60%)
A lead plaintiff is formally recognized, and the class action proceeds toward discovery and potential settlement.
- Successful filing of lead plaintiff motions by September 28, 2026
Downside: Lack of organized lead plaintiff (25%)
The litigation stalls or is handled by smaller, less influential firms, reducing the pressure on the company.
- Failure to meet the September 28 deadline with substantial investor interest
Upside: Rapid settlement agreement (15%)
Early movement in the litigation leads to a settlement before full trial proceedings, providing quicker but potentially smaller payouts.
- Company reaches an early agreement with representative shareholder groups
What to watch
- September 28, 2026: Lead plaintiff deadline for Capricor Therapeutics
- September 21, 2026: Lead plaintiff deadline for Cogent Communications (CCOI)
Timeline
- — Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Counsel (PR Newswire)
- — Faruqi & Faruqi, LLP Urges Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors to Seek Counsel (PR Newswire)
- — Faruqi & Faruqi, LLP Urges Microvast Holdings, Inc. (NASDAQ: MVST) Investors to Seek Counsel (PR Newswire)
- — Faruqi & Faruqi, LLP Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors to Seek Counsel (PR Newswire)
- — Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Cogent Communications (PR Newswire)
Analysis — what this means
Likely next events
- September 28, 2026: Lead plaintiff deadline for CAPR shareholders
Sectors affected
- Biotechnology
- Securities Litigation
Regulatory implications
- SEC oversight regarding disclosures that triggered the class action
Historical parallels
- Multiple ongoing securities class actions involving Nasdaq-listed companies as seen in recent law firm notices
Key entities
Sources
- Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Counsel — PR Newswire
- Faruqi & Faruqi, LLP Urges Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors to Seek Counsel — PR Newswire
- Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Cogent Communications — PR Newswire
- Faruqi & Faruqi, LLP Urges Microvast Holdings, Inc. (NASDAQ: MVST) Investors to Seek Counsel — PR Newswire
- Faruqi & Faruqi, LLP Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors to Seek Counsel — PR Newswire
Related cases
- Robbins LLP urges GoDaddy investors to step forward as lead plaintiff in a recently filed securities fraud class action
- Robbins LLP is seeking lead plaintiffs for a class action against Taboola, signalling potential securities‑fraud litigation that could affect the ad‑tech company’s legal costs and share price
- Chinese e-commerce sellers seek to nullify thousands of US default judgments obtained via email after Seventh Circuit deemed such service invalid
- Capricor Therapeutics faces growing legal pressure as investors approach deadline for class action leadership amidst FDA review uncertainties
- Regeneron Pharmaceuticals faces critical deadline for lead plaintiff selection in securities class action lawsuit
- Robbins Geller Rudman & Dowd LLP sets final deadline for Cogent Communications shareholders to lead securities class action lawsuit